Tompkins W A, Seth P B, Yip D M, Palmer J L, Gee S R, Rawls W E
J Immunol. 1976 Nov;117(5 Pt.2):1943-8.
The 51Cr cytotoxicity test was used to measure specific antibody reactions against carcinoembryonic antigen (CEA) and isoantigen A on the surface of human colon tumor cells. When human serum or guinea pig serum was used as a source of complement, no anti-CEA or anti-isoantigen A cytotoxicity was demonstrable despite binding of specific antibodies and activation of complement at least through the C3 component on the cell surface. In contrast, specific anti-CEA and anti-isoantigen A cytotoxicity was demonstrated when rabbit serum was used as a source of complement. Specific antibody-mediated cell lysis was also achieved with guinea pig complement if the cells were treated with neuraminidase before testing. These results support the concept that certain tumor cells have surface properties that render them resistant to immune lysis.
采用51Cr细胞毒性试验来检测针对人结肠肿瘤细胞表面癌胚抗原(CEA)和同种抗原A的特异性抗体反应。当用人血清或豚鼠血清作为补体来源时,尽管特异性抗体发生了结合且补体至少通过细胞表面的C3成分被激活,但未显示出抗CEA或抗同种抗原A的细胞毒性。相比之下,当用兔血清作为补体来源时,可显示出特异性抗CEA和抗同种抗原A的细胞毒性。如果在检测前用神经氨酸酶处理细胞,用豚鼠补体也能实现特异性抗体介导的细胞裂解。这些结果支持了这样一种概念,即某些肿瘤细胞具有使其对免疫裂解产生抗性的表面特性。